Skip to content

Identification and validation of the co-pathogenesis and key biomarkers of papillary thyroid carcinoma with rheumatoid arthritis

Identification and validation of the co-pathogenesis and key biomarkers of papillary thyroid carcinoma with rheumatoid arthritis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400080634
Enrollment
Unknown
Registered
2024-02-04
Start date
2024-02-04
Completion date
Unknown
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid cancer

Interventions

Experimental group (Patients also have papillary thyroid cancer and rheumatoid arthritis):None
Control group (Patients only have papillary thyroid cancer):None

Sponsors

The Second Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Gender is not limited; 2. Preoperative FNA and postoperative pathological type were papillary thyroid carcinoma; 3. Patients with rheumatoid arthritis have not been cured; 4. Can comply with the research visit plan and other program requirements; 5. If patients voluntarily participate in and sign the informed consent, they can participate in this study after voluntarily signing the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with internal medical diseases accompanied by serious comorbidities cannot tolerate general anesthesia or conventional surgical positions; 2. Previous history of thyroid surgery or thermal ablation; 3. Other pathological types of thyroid cancer were identified.

Design outcomes

Primary

MeasureTime frame
Dyeing effect;

Countries

China

Contacts

Public ContactChao DIng

The Second Affiliated Hospital of Harbin Medical University

dingchao851221@163.com+86 139 3631 4986

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026